Literature DB >> 1931707

Interferon alpha in the therapy of CML.

M Talpaz1, H Kantarjian, R Kurzrock, J U Gutterman.   

Abstract

This paper summarizes the experience with interferon alpha (IFN alpha) as single-agent therapy and in combination gathered at M.D. Anderson Cancer Center. It also covers some of the laboratory research associated with these clinical studies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1931707     DOI: 10.1111/j.1365-2141.1991.tb08117.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

Review 1.  The Cure of Chronic Myeloid Leukemia: Are We There Yet?

Authors:  Tapan Saikia
Journal:  Curr Oncol Rep       Date:  2018-02-28       Impact factor: 5.075

2.  Treatment of lymphangioleiomyomatosis by ovariectomy, interferon alpha 2b and tamoxifen--a case report.

Authors:  M Klein; O Krieger; R Ruckser; A Rosen; R Waldner; P Preis; A Beck
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.